Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

One pill to rule blood sugar: triple combo tested in 800 patients

NCT ID NCT06862739

First seen Apr 19, 2026 · Last updated May 24, 2026 · Updated 6 times

Summary

This study tests a single pill that combines three common diabetes medicines (empagliflozin, linagliptin, and metformin) to see if it helps people with type 2 diabetes control their blood sugar better. About 800 adults aged 18-80 with high blood sugar (HbA1c 8% or above) who already take at least two diabetes drugs will take part. The goal is to improve blood sugar levels, quality of life, and treatment satisfaction while reducing side effects like low blood sugar.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Aap ka Clinic

    RECRUITING

    Lahore, Punjab Province, Pakistan

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

  • Faisalabad clinics

    RECRUITING

    Faisalabad, Punjab Province, Pakistan

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.